Retrophin Says Q4 Sales Rise

Retrophin Says Q4 Sales Rise

Retrophin said on Monday it sees Q4 net product sales of about $37 million, 22% higher than in the same quarter a year earlier, according to preliminary results. A year ago, the company reported $30.4 million in revenue. The revenue beat analyst estimates of $36 million, according to a poll published by Capital IQ. Full-year net product sales in 2016 totaled about $134 million, compared with $99.9 million in 2015 […]

Read More ˃
Vanda Sees Q4 Revenues Below Street Estimate

Vanda Sees Q4 Revenues Below Street Estimate

Vanda Pharmaceuticals said Monday that it expects to report total net product sales from Hetlioz and Fanapt of approximately $38 million for Q4, and approximately $146 million for full year 2016. The Street estimates call for total revenues of $39.7 million and $147.5 million for Q4 and 2016, respetively. For 2017, the company expects net product sales from Hetlioz and fanapt of between $165 million and $175 million. Cash is […]

Read More ˃